HDAC7 Is a Repressor of Myeloid Genes Whose Downregulation Is Required for Transdifferentiation of Pre-B Cells into Macrophages by Barneda-Zahonero, B. (Bruna) et al.
HDAC7 Is a Repressor of Myeloid Genes Whose
Downregulation Is Required for Transdifferentiation of
Pre-B Cells into Macrophages
Bruna Barneda-Zahonero1., Lidia Roma´n-Gonza´lez1., Olga Collazo1, Haleh Rafati2,
Abul B. M. M. K. Islam3¤, Lars H. Bussmann4, Alessandro di Tullio4, Luisa De Andres4, Thomas Graf4,5,
Nu´ria Lo´pez-Bigas3,5, Tokameh Mahmoudi2, Maribel Parra1¤*
1Cancer Epigenetics and Biology Program (PEBC), Bellvitge Biomedical Research Institute (IDIBELL), Barcelona, Spain, 2 Erasmus University Medical Center, Department of
Biochemistry, Rotterdam, The Netherlands, 3 Research Unit on Biomedical Informatics, Department of Experimental and Health Sciences, Universitat Pompeu Fabra,
Barcelona, Spain, 4Center for Genomic Regulation, Barcelona, Spain, 5 Institucio´ Catalana de Recerca i Estudis Avanc¸ats (ICREA), Barcelona, Spain
Abstract
B lymphopoiesis is the result of several cell-commitment, lineage-choice, and differentiation processes. Every differentiation
step is characterized by the activation of a new, lineage-specific, genetic program and the extinction of the previous one. To
date, the central role of specific transcription factors in positively regulating these distinct differentiation processes to
acquire a B cell–specific genetic program is well established. However, the existence of specific transcriptional repressors
responsible for the silencing of lineage inappropriate genes remains elusive. Here we addressed the molecular mechanism
behind repression of non-lymphoid genes in B cells. We report that the histone deacetylase HDAC7 was highly expressed in
pre-B cells but dramatically down-regulated during cellular lineage conversion to macrophages. Microarray analysis
demonstrated that HDAC7 re-expression interfered with the acquisition of the gene transcriptional program characteristic of
macrophages during cell transdifferentiation; the presence of HDAC7 blocked the induction of key genes for macrophage
function, such as immune, inflammatory, and defense response, cellular response to infections, positive regulation of
cytokines production, and phagocytosis. Moreover, re-introduction of HDAC7 suppressed crucial functions of macrophages,
such as the ability to phagocytose bacteria and to respond to endotoxin by expressing major pro-inflammatory cytokines.
To gain insight into the molecular mechanisms mediating HDAC7 repression in pre-B cells, we undertook co-
immunoprecipitation and chromatin immunoprecipitation experimental approaches. We found that HDAC7 specifically
interacted with the transcription factor MEF2C in pre-B cells and was recruited to MEF2 binding sites located at the
promoters of genes critical for macrophage function. Thus, in B cells HDAC7 is a transcriptional repressor of undesirable
genes. Our findings uncover a novel role for HDAC7 in maintaining the identity of a particular cell type by silencing lineage-
inappropriate genes.
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Introduction
The generation of B cells is the result of several cellular
transitions that take place in a stepwise manner and comprise cell
lineage choices, cell commitment and differentiation. Every
differentiation step leads to the activation of specific genes
characteristic of the new cellular stage. This is achieved by the
action of well defined networks of transcription factors specific to
each particular cellular state [1,2]. In the bone marrow,
lymphocyte development begins at the lymphoid-primed multip-
otent progenitor (LMPPs) stage. LMPPs become common
lymphoid progenitors (CLPs), which have the potential to
differentiate into B and T lymphocytes, as well as natural killer
(NK) cells [3]. The transcription factors IKAROS, PU.1 and
MEF2C are critical for the cellular commitment of LMPPs to the
lymphoid lineage [3–5]. Later, the transcription factors E2A, EBF
and FOXO-1 are required for the early specification of CLPs into
pro-B cells, whereas PAX5 is required to maintain B cell identity
along differentiation into mature B cells [6–11]. However, there is
an increasing body of evidence indicating that the repression of
lineage inappropriate genes is a pivotal mechanism to properly
acquire a particular cellular state during B lymphopoiesis. For
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example, PAX5 not only induces the expression of a B-cell specific
genetic program, it also suppresses inappropriate genes of
alternative lineages, thereby ensuring its role in maintaining B
cell identity and differentiation [12–14]. Recently, it has been
reported that the transcription factor MEF2C, by activating
lymphoid specific genes and repressing myeloid genes, is involved
in the cellular choice towards the lymphoid lineage [5]. These
studies suggest that B cell transcription factors must also recruit
transcriptional co-repressors to silence undesirable genes. To date,
very little is known on the role of transcriptional repressors during
B lymphopoiesis.
Histone deacetylases (HDACs) have emerged as crucial
transcriptional co-repressors in highly diverse physiological
systems. To date, 18 human HDACs have been identified and
grouped into four classes. Class I HDACs (HDAC1, 2, 3, and 8),
class II HDACs (HDAC4, 5, 6, 7, 9, and 10), class III HDACs,
also called sirtuins, (SIRT1, 2, 3, 4, 5, 6, and 7) and class IV
HDAC (HDAC11). Class II HDACs are further subdivided into
class IIa (HDAC4, 5, 7, 9) and class IIb (HDAC6 and 10) [15,16].
Unlike other HDACs, Class IIa HDACs have three unique
features. First, they are expressed in a tissue-specific manner and
are involved in development and differentiation processes. They
exert their transcriptional repressive function in skeletal, cardiac,
and smooth muscle, the bone, the immune system, the vascular
system, and the brain among others. Second, they are signal-
dependent co-repressors which become phosphorylated at con-
served serine residues in the regulatory N-terminal domain leading
to their nuclear export. Third, they contain a regulatory N-
terminal domain that mediates their interactions with tissue-
specific transcription factors such as members of the MEF2 family
[15,16]. This last feature prompted us to ask whether members of
the class IIa HDACs subfamily could be lineage-specific
transcriptional repressors crucial to maintain B cell identity and
biology.
To address this question we have used a cellular transdiffer-
entiation system that we reported recently [17]. This system
consists of a pre-B cell line (HAFTL cells) transduced with a
retroviral vector for stable expression of a b-estradiol-inducible
form of C/EBPa (C10 and C11 cells). After addition of b-estradiol,
C10 and C11 cells are converted into functional macrophage-like
cells at 100% efficiency within 48–72 hours. The conversion of
pre-B cells into macrophages is direct and does not involve overt
retro-differentiation through hematopoietic stem and progenitor
cells [18]. Unexpectedly, this cellular transdifferentiation process
appears to occur in the absence of significant changes in the DNA
methylation status of key lymphoid or myeloid genes, but involves
changes in histone modification on both types of genes [19]. Since
HAFTL cells are a fetal liver cell line immortalized by Ha-ras
transformation we, in parallel, also investigated the involvement of
class IIa HDACs in normal primary B cell precursors. Here, we
report that during the conversion of pre-B cells into macrophages,
HDAC7 expression is down-regulated. In pre-B cells HDAC7
specifically interacts with the transcription factor MEF2C and is
recruited to putative MEF2 sites located at the promoters of key
macrophage genes. Forced re-expression of HDAC7 interferes
with the establishment of the gene transcriptional program and
functional characteristics of macrophages. Importantly, HDAC7
depletion in pre-B cells results in the de-repression of macrophage
genes.
Results
HDAC7 is down-regulated during the transdifferentiation
of pre-B cells into macrophages
In order to study the potential role of class IIa HDACs in B
lymphocyte biology we first analyzed their expression levels during
the cellular transdifferentiation of pre-B cells into macrophages.
RT-qPCR and Western blotting experimental approaches showed
that HDAC7 expression was dramatically down-regulated during
the conversion of C10 cells into macrophages at 72 hours after b-
estradiol treatment (Figure 1A and 1B). Notably, no changes in
Hdac4, Hdac5 and Hdac9 expression levels were observed during
the cellular reprogramming process. As previously described [17],
the B cell genes Rag1 and Pax5 became down-regulated, whereas
the expression of the myeloid genes C/Ebpb and Csf1r were up-
regulated during cellular reprogramming (Figure 1A). Consistent
with our findings, HDAC7 is not present in RAW264.7
macrophages at neither the RNA nor protein levels (Figure 1A
and 1B). As expected, the expression of the B cell transcription
factors IKAROS, E2A, EBF and PAX5 were down-regulated
during the cellular conversion. In contrast, protein levels of the
transcription factors MEF2C and RUNX1 did not significantly
change during transdifferentiation (Figure 1B). To further confirm
our findings we analyzed the kinetics of HDAC7 expression during
the cellular transdifferentiation in our previously reported
microarray experiments [17]. Strikingly, similar to the B cell
specific transcription factor PAX5, HDAC7 expression was down-
regulated during cellular reprogramming (Figure S1). Since
HAFTL cells are a fetal-derived pre-B cell line transformed by
Ha-ras we wondered whether our findings could be extended to
normal primary cells. We analyzed HDAC7 expression in both
primary B cell precursors and primary macrophages in a recently
reported microarray analysis [18]. Importantly, we found that,
similar to PAX5, HDAC7 was highly expressed in B cell
precursors compared to primary macrophages (Figure 1C and
Figure S1). In agreement with our results with the C10 cell line,
C/EBPa-mediated conversion of primary pre-B cells into macro-
phages also resulted in the down-regulation of HDAC7 (Figure 1C
and Figure S1). Our data demonstrate that among the different
class IIa HDACs, HDAC7 shows a lymphoid-specific expression
pattern and suggest that by repressing lineage inappropriate genes
Author Summary
Through the hematopoietic system, all the distinct mature
blood cell types are generated, thereby constituting one of
the best-studied paradigms for cell lineage commitment
and differentiation in biology. B lymphocytes are gener-
ated through several cell-commitment, lineage-choice, and
differentiation processes. To date, the central role of
lineage-specific transcription factors in positively regulat-
ing these distinct developmental steps is well established.
However, in the absence of proper transcriptional repres-
sion, an ‘‘adolescent cell’’ will never be able to reach its
‘‘adulthood identity,’’ having a potential impact in the
development of hematological malignancies. In this article,
we examined the molecular mechanism responsible for
the gene silencing of lineage undesirable genes in B cell
precursors and uncovered the role played in this process
by the histone deacetylase HDAC7. We show that HDAC7
is expressed in B cell precursors where it interacts with the
transcription factor MEF2C and is recruited to the
promoters of non-B cell genes. While HDAC7 is down-
regulated during the lineage conversion of pre-B cells into
macrophages, re-expression of HDAC7 interferes with both
the acquisition of the myeloid gene transcriptional
program and macrophage-specific cell functions. We
therefore have identified a novel lineage-specific tran-
scriptional repressor in the hematopoietic system.
HDAC7 Is a Key Repressor in Pre-B Cells
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Figure 1. HDAC7 is down-regulated during the transifferentiation of pre-B cells into macrophages. A. RT-qPCR experiments for gene
expression changes of class IIa HDACs, B cell and macrophages genes (uninduced cells (2) and b-estradiol induced C10 cells (+) for 72 hours). HAFTL
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in pre-B cells, such as genes characteristic of macrophages,
HDAC7 might be crucial in maintaining B cell functions and
identity.
HDAC7 re-expression interferes with the gene
transcriptional program of the reprogrammed
macrophages
Our observed dramatic down-regulation of HDAC7 upon
transdifferentiation of pre-B cells into the macrophage lineage was
consistent with its potential role as a transcriptional repressor of
macrophage-specific genes in pre-B cells. To test whether the
presence of HDAC7 could interfere with the acquisition of a
macrophage-specific gene program during transdifferentiation of
pre-B cells into macrophages, we performed a gain of function
experimental approach followed by genome-wide microarray
analysis. We transduced C10 cells with a retroviral vector carrying
HDAC7-Flag (C10-HDAC7 cells). As a control, C10 cells were
transduced with an empty retroviral vector (C10-MSCV cells). As
expected, b-estradiol treatment of C10-MSCV cells resulted in the
total down-regulation of endogenous HDAC7 protein levels, while
C10-HDAC7 cells expressed the exogenous HDAC7 protein at
similar levels as in untreated C10-MSCV cells even at 72 hours
after b-estradiol treatment (Figure S2). We then examined the
genome-wide effects of HDAC7 re-expression on the gene
transcription program of C10 cells induced to transdifferentiate
to macrophages. Microarray experiments were conducted in both
C10-MSCV and C10-HDAC7 cells un-induced or induced to
transdifferentiate for 48 and 72 hours. The addition of b-estradiol
to C10-MSCV cells resulted in the up- and down-regulation of
1609 and 1798 genes at 48 hours and of 1531 and 1567 genes at
72 hours after treatment, in agreement with our previous report
[17]. Importantly, the exogenous expression of HDAC7 in C10-
HDAC7 cells treated with b-estradiol totally or partially abrogated
the up-regulation of 988 and 866 genes, after 48 and 72 hours
respectively. Earlier analyses showed that the vast majority of the
up-regulated genes correspond to key genes for macrophage
function, whereas the down-regulated genes are associated with
cell cycle processes and with important functions for B cell
development and biology [17]. To determine the type of genes
whose up-regulation was affected by the presence of HDAC7 we
performed a gene set enrichment analysis based on the gene
ontology (GO) categories corresponding to Biological Processes,
Cellular Components and Molecular Functions, as well as on
KEGG pathways. To do so we took advantage of Gitools, a
recently developed bioinformatics tool [20]. Gitools allows
accessing many available biological databases, performing analysis
and visualizing data using interactive heat-maps. Strikingly, the
Biological Process enrichment revealed that the set of up-regulated
genes affected by HDAC7 belong to GO categories representing
key macrophage related functions, such as immune, inflammatory
and defense response, cellular response to infections, positive
regulation of cytokines production and phagocytosis (Figure 2A).
Importantly, we found that the categories enriched in the KEGG
pathways analysis correspond to similar biological processes
(Figure S3). Gene ontology (GO) analysis corresponding to
Cellular Components and Molecular Functions reinforce the
above results (Figure 2B and 2C). Among the genes whose up-
regulation is impaired by HDAC7 we found several that are
involved in phagocytosis (such as Fcgr1, Fcgr2b and Fcgr3), genes
related to the immune response (such as the chemokine genes
Cxcl10, Cxcl11 and Ccl2), Toll-like receptors (Tlr3, Tlr4, Tlr7, Tlr8
and Tlr9), interleukins (Il18 and Il15) and TNF pathway-related
genes (Tnfsf10, Tnfsf11 and Tnfsf13b) (Figure 3). A full list of the
genes found in each category is presented in the interactive website
http://bg.upf.edu/C10-HDAC7/ (for statistics see Dataset S1).
To validate our microarray analysis, we selected several represen-
tative genes and tested their mRNA levels by RT-qPCR. We
observed that the presence of HDAC7 significantly interfered with
the increase in the mRNA levels of Cxcl10, Fcgr1, Ifi35, Ifi47, Tlr3,
Tlr9, Il18 and C3 genes after b-estradiol treatment (Figure 4).
Importantly, HDAC7 re-introduction did not interfere with the
down-regulation of key genes for B cell differentiation and biology
such as the transcription factor PAX5, reinforcing the notion that
HDAC7 is a repressor of macrophage genes in B cell precursors
(Figure S5). During the trasdifferentiation of C10 cells into
macrophages the cells stop dividing and many genes related to the
cell cycle, such as genes involved in mitosis, become down-
regulated [17]. We have observed that the presence of HDAC7
also interferes with the down-regulation of these types of genes,
corroborating that HDAC7 blocks, at least in part, the cellular
transdifferentiation process (Figure S4, Dataset S2, and interactive
website http://bg.upf.edu/C10-HDAC7/). Our data clearly
demonstrate that HDAC7 represses the expression of central
genes for macrophage function, and strongly suggest that HDAC7
acts as a specific transcriptional repressor of lineage inappropriate
genes in B cell precursors.
HDAC7 knock down leads to the de-repression of
macrophage genes
To determine the physiological function of HDAC7 in B cell
precursors and test whether it is involved in the repression of
macrophage genes, we performed a loss of function experimental
approach. We knocked down HDAC7 by siRNA in both HAFTL
cells and primary pre-B cells (Figure 5). Strikingly, we observed
that the reduction in HDAC7 mRNA levels resulted in the de-
repression of key macrophage genes such as Itgam (Mac-1), Fcgr1
and Ccl3 (Figure 5). These data demonstrate that HDAC7 is
involved in the repression of lineage inappropriate genes in B cell
precursors.
HDAC7 binds to the transcription factor MEF2C in pre-B
cells and is recruited to the promoters of target genes
critical for macrophage function
At the mechanistic level, class IIa HDACs exert their actions as
transcriptional repressors by interacting with specific transcription
factors recruited to the promoters of genes required for
development and cell differentiation [15,16]. To address whether
HDAC7 specifically interacts with particular sequence-specific
transcription factors in pre-B cells, we undertook a candidate
approach and performed co-immunoprecipitation experiments to
test for potential interaction between endogenous HDAC7 and the
B cell transcription factors IKAROS, E2A, PAX5, and MEF2C in
the C10 parental line (HAFTL cells). HDAC7 specifically
associated with MEF2C, but not with the other B cell transcription
pre-B cells and RAW264.7 cells were used as control. Data are represented as the mean +/2 standard error of the mean (SEM) of three independent
experiments. B. Western blot of Class IIa HDACs and B cell transcription factors in the same experimental conditions shown in A. C. RT-qPCR
experiments for gene expression changes of Hdac7, Pax5, Rag1 and Csf1r genes (uninduced (0) and b-estradiol induced primary pre-B cells transduced
with a retroviral vector for C/EBPa expression for the indicated times. Primary macrophages were used as control.
doi:10.1371/journal.pgen.1003503.g001
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factors tested (Figure 6A). Recently, Camargo and colleagues have
reported that MEF2C is crucial in the cellular choice towards the
lymphoid versus the myeloid lineage in LMPPs [5]. Microarray
analysis of control and MEF2C-deficient LMPPs revealed that the
absence of MEF2C resulted in the up-regulation of genes enriched
in GO categories related to the immune system, such as genes
involved in the inflammatory and defense response of the cells [5].
Comparison of these data with our set of genes whose up-
regulation was affected by HDAC7 re-expression during cellular
transdifferentiation showed a significant overlap by Chi-square test
of 46 (p,1026) and 30 (p = 0.00044) genes, respectively
(Figure 6B). Strikingly, the phagocytosis-related genes Fcgr1, Fcgr2b
and Fcgr3 were found to be targets of both HDAC7 and MEF2C.
These data indicate that MEF2C represses genes characteristic of
macrophages in hematopoietic progenitors and suggest that
HDAC7 may also silence lineage inappropriate genes at earlier
stages of lymphocyte development.
To test whether in pre-B cells HDAC7 is recruited to the
promoters of macrophage-specific genes whose up-regulation is
impaired in the presence of exogenously expressed HDAC7, we
performed chromatin immunoprecipitation (ChIP) assays. Nota-
bly, using the TFconsite bioinformatic tool we found that
Figure 2. HDAC7 re-expression interferes with the gene transcriptional program of the converted macrophages. Heat-maps showing
significantly (corrected p-value,0.05) enriched GO Biological Process (A), Cellular Components (B) and Molecular Functions (C) categories among the
up-regulated genes affected by the re-expression of HDAC7 during transdifferentiation of pre-B cells into macrophages. Colours toward red indicate
high statistic significance, yellow indicates low statistic significance, and gray indicates no statistical significance. The list of genes for the enrichment
analysis in each column is as follows: C10-MSCV-48h includes genes up-regulated after b-estradiol treatment for 48 hours. C10-HDAC7-48h includes
genes up-regulated after b-estradiol treatment for 48 hours which are down-regulated in the presence of HDAC7 (HDAC7 re-expression). C10-MSCV-
72h includes genes up-regulated after b-estradiol treatment for 72 hours. C10-HDAC7-72h includes genes up-regulated after b-estradiol treatment
for 72 hours which are down-regulated after re-expression of HDAC7.
doi:10.1371/journal.pgen.1003503.g002
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promoters of Fcgr1, Cxcl10 and Itgam contain putative MEF2
binding sites. We designed primers spanning the upstream
regulatory regions, gene body, and downstream regulatory regions
of mouse Fcgr1, Cxcl10 and Itgam (Figure 6C and 6F and Figure
S6A). Chromatin prepared from C10 cells un-induced or induced
with b-estradiol for 72 hours was subjected to ChIP with
antibodies specific for MEF2C and HDAC7. qPCR analysis of
the immunoprecipitated material with primers specific for the
Figure 3. HDAC7 re-expression interferes with the gene transcriptional program of the converted macrophages. Heat-maps showing
observed differentially expressed genes for selected enriched GO categories. Blue colour cell indicates positive events while gray colour indicates that
the gene was not observed differentially expressed in that experimental condition.
doi:10.1371/journal.pgen.1003503.g003
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Figure 4. RT–qPCR for microarray validation of selected genes. RT-qPCR experiments for gene expression changes for 8 up-regulated genes,
Cxcl10, Fcgr1, Ifi35, Ifi47, Tlr3, Tlr9, Il18 and C3 in the absence or in the presence of HDAC7. Data are represented as the mean +/2 standard error of the
mean (SEM) of three independent experiments. The two-way ANOVA test was used to calculate significant levels between the indicated groups.
*P,0.001.
doi:10.1371/journal.pgen.1003503.g004
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Fcgr1, Cxcl10 and Itgam loci indicated that both MEF2C and
HDAC7 were specifically and significantly enriched at the
identified putative MEF2 binding sites in un-induced C10 cells
(Figure 6D, 6E, 6G and 6H and Figure S6B). Importantly, while
significant MEF2C enrichment around its putative binding sites
was found in both un-induced and induced conditions, HDAC7
enrichment at the target genes was lost upon b-estradiol induction
(Figure 6D, 6E, 6G and 6H and Figure S6B). Taken together these
data indicate that via interaction with MEF2C, HDAC7 is
recruited to the promoters of myeloid genes in B cell precursors,
resulting in their transcriptional silencing.
HDAC7 re-expression interferes with the functional
properties of the reprogrammed macrophages
We previously reported that during reprogramming of pre-B
cells into macrophages there is an increase in the expression of
Mac-1 and a down-regulation of CD19 levels, two cell surface
markers characteristic for macrophages pre-B cells, respectively.
The reprogrammed macrophages show high phagocytic activity
and respond to LPS treatment with cytokine production [17]. To
test whether the presence of HDAC7 could interfere with the
functional characteristics of the reprogrammed macrophages we
undertook three different experimental approaches. First, we
followed the expression kinetics of CD19 and Mac-1 (CD11b), two
cell surface markers characteristic for pre-B cells and macrophag-
es, respectively by flow cytometry. In both C10-MSCV and C10-
HDAC7 cells, 100% of the population became CD19 negative
and Mac-1 positive 72 hours after addition of b-estradiol
(Figure 7A). However, the presence of exogenous HDAC7 resulted
in a significant block in the expression levels of Mac-1 (Figure 7A
and 7B). In contrast, CD19 protein levels decreased to the same
extent regardless of the presence of HDAC7 (Figure 7A and 7B).
Exogenous expression of HDAC7 in primary B cell precursors also
interfered with the up-regulation of Mac-1 in transdifferentiation
experiments (Figure 7C). These results demonstrated that in the
presence of HDAC7 the reprogrammed cells are not able to
express the levels of Mac-1 protein normally present in macro-
phages. Second, we tested the phagocytic properties of the
transdifferentiated C10 cells exogenously expressing HDAC7.
Interestingly, C10-HDAC7 cells treated with b-estradiol showed a
significantly reduced capacity to phagocytose red fluorescence
protein-expressing bacteria compared to the control C10-MSCV
cells (Figure 7D). Lastly, we analyzed the inflammatory response of
both cell lines after treatment with LPS in the presence or absence
of b-estradiol for 48 hours. Strikingly, expression of HDAC7
resulted in a significant inhibition in the expression of the pro-
inflammatory cytokines, Tnfa, Il-1a and Il-6, by the macrophage-
like converted cells in response to LPS (Figure 7E). We next tested
whether HDAC7 re-expression results in the reduction of Mac-1
protein levels once the cells have been reprogrammed into
macrophages. We first treated C10 cells with b-estradiol for
72 hours and the reprogrammed macrophages were transduced
with a retroviral vector carrying HDAC7-Flag. We observed a
decrease in the expression levels of Mac-1 24 hours after
expression of exogenous HDAC7 (Figure S7A). However, we did
not observe any effect on either the expression of macrophage
genes or the phagocytic capacity of RAW cells expressing
exogenous HDAC7 (Figure S7B, S7C and S7D). We have recently
shown that C/EBPa-mediated reprogramming of pre-B cells into
macrophages occurs in the absence of significant changes in the
DNA methylation of crucial genes suggesting that the repro-
grammed macrophages retained an epigenetic memory charac-
teristic of the cell of origin [19]. Therefore, we speculate that the
chromatin structure present in differentiated macrophages is not
permissive for the recruitment of HDAC7 to its target genes and
that such recruitment is only possible in a chromatin environment
characteristic of B cells, in line the notion that HDAC7 is a
lymphoid-specific transcriptional repressor. Taken together, these
results demonstrate that HDAC7 significantly interferes with key
functional characteristics of the transdifferentiated macrophages.
Interaction of HDAC7 with MEF2C and its catalytic
activity are essential for repression of Mac-1
Class IIa HDACs interact with MEF2 proteins via a conserved
motif of 17 amino acids located in the amino-terminal region of
the proteins. To definitively prove that HDAC7 represses
macrophage genes through its interaction with MEF2C, we
generated retroviral vectors carrying mutants of HDAC7 with
either a deletion of the entire 17 amino acids stretch (HDAC7-
DMEF) or with substitutions of crucial lysine residues (HDAC7-
K86AK88A). We tested the HDAC7 mutants for their ability to
repress Mac-1 during the transdifferentiation of pre-B cells into
macrophages. Expression of wild-type HDAC7 resulted in a
significant decrease in Mac-1 positive cells and mRNA levels
(Figure 8) whereas expression of the HDAC7 mutants defective for
MEF2C binding had no significant effect. We next tested whether
the enzymatic activity of HDAC7 is necessary for its repressive
action on Mac-1 expression during the conversion of pre-B cells
into macrophages. We generated a retroviral vector for HDAC7
mutated in its catalytic domain (HDAC7-H657A), a C-terminal
truncated construct HDAC7(1–487) that completely lacks the
HDAC catalytic domain but contains the MEF2 interacting motif
and a N-terminal truncated construct HDAC7(438–915) bearing
the enzymatic motif but lacking the MEF2 domain. As shown in
Figure 8, forced expression of wild-type HDAC7 interfered with
the up-regulation of Mac-1 protein levels 48 hours after induction
of cellular reprogramming. In contrast, the HDAC7-H657A, the
HDAC7(1–487) and the HDAC7(438–915) constructs did not
block the up-regulation of Mac-1 levels. These experiments
demonstrate that both the HDAC7-MEF2C interaction, as well
as its catalytic activity, are necessary for HDAC7 to repress
macrophage genes during cellular reprogramming.
Discussion
Our findings have revealed that HDAC7 is expressed in B cell
precursors and not in macrophages (Figure 9). Using a cellular
transdifferentiation system we have demonstrated that HDAC7
represses the expression of a large number of macrophage genes
during the conversion of pre-B cells into this myeloid cell type.
More importantly, depletion of HDAC7 in pre-B cells results in
the de-repression of key macrophage genes. Functionally, the
presence of HDAC7 interferes with the acquisition of key
functional features of the converted macrophages. These aberrant
macrophage-converted cells do not express the Mac-1 protein
levels normally present in macrophages, are not able to properly
Figure 5. HDAC7 knock down leads to the de-repression of macrophage genes. HAFTL cells (A) and primary B cell precursors (B) were
transfected with control siRNA or siRNAs targeting HDAC7. 72 hours after transfection Hdac7, Itgam, Fcgr1 and Ccl3 mRNA levels were determined by
RT-qPCR experiments. Data are represented as the mean +/2 standard error of the mean (SEM) of three independent experiments. The two-way
ANOVA test was used to calculate significant levels between the indicated groups. *P,0.001.
doi:10.1371/journal.pgen.1003503.g005
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Figure 6. HDAC7 binds to the transcription factor MEF2C and is recruited to the promoter of key genes for macrophage function in
pre-B cells. A. Co-immunoprecipitation experiments showing the specific binding of HDAC7 with MEF2C in pre-B cells. HDAC7 does not bind with
IKAROS, PAX5 and E2A. B. Venn diagrams showing the total number of genes up-regulated in MEF2C deficient LMPPs, genes up-regulated at 48 and
72 hours of b-estradiol treatment affected by HDAC7 and the overlapping between both conditions. C and F. Schematic representation of the mouse
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phagocytose bacteria and do not respond adequately to endotoxin
by expressing major pro-inflammatory cytokines. At the mecha-
nistic level, HDAC7 specifically interacts with the transcription
factor MEF2C in pre-B cells and is recruited to MEF2 binding
sites located at the promoters of genes critical for macrophage
function (Figure 6 and Figure S6). In addition to the interaction
with MEF2C, the catalytic activity of HDAC7 is also necessary to
repress macrophage genes. Our results demonstrate that HDAC7
is expressed in fetal and adult pre-B cells suggesting that it might
play a role in both types of B lymphopoiesis.
Why is HDAC7 specifically expressed in pre-B cells and not
macrophages? Based on our results, we conclude that HDAC7 is a
key transcriptional repressor of lineage inappropriate genes in pre-
B cells. Using a ChIP-seq approach Murre and colleagues have
identified HDAC7 as a target of the transcription factors E2A,
EBF and Foxo1 in B cell precursors (pro-B cells) postulating that it
could be an important regulator of B cell development and
indicating that HDAC7 function is not restricted to T cells within
the hematopoietic system [21]. In addition, our results showing
that in pre-B cells HDAC7 interacts with the transcription factor
MEF2C, allowing the recruitment to the MEF2 binding sites on
promoters of genes characteristic of macrophages reinforces our
conclusion. Indeed, in the late nineties, MEF2C was found, among
the different MEF2 family members, to be specifically expressed in
B cells within the lymphocyte lineage, suggesting that it could have
a role in B cell development and function [22]. More recently, it
has been reported that MEF2C regulates B cell proliferation and
survival after BCR activation and p38 MAPK signaling [23,24].
MEF2C is also expressed at earlier stages of lymphocyte
development [5,25]. It has been reported that MEF2C is involved
in the cellular choice towards the lymphoid versus the myeloid
lineage in lymphoid-primed multipotent progenitors (LMPPs)
[25]. At the molecular level MEF2C activates the transcription of
lymphoid specific genes and represses myeloid genes [25]. We
have observed a significant overlap between MEF2C regulated
genes in LMPPs and our identified HDAC7 target genes in pre-B
cells. Moreover, HDAC7 mutants that do not interact with
MEF2C are unable to suppress the up-regulation of macrophage
genes during the reprogramming process. Given this scenario, we
propose that HDAC7 is the MEF2C transcriptional co-repressor
responsible for the silencing of myeloid genes in B cells and
lymphoid precursors.
Finally, in light of previous reports demonstrating the expression
and functions of HDAC7 in T cells, our results have uncovered a
more general role for HDAC7 in the lymphoid lineage compart-
ment within the hematopoietic system. In addition, the finding
that HDAC7 is dramatically down-regulated during the transdif-
ferentiation of pre-B cells into macrophages not only reinforces
this notion, but also provides an additional level of complexity to
the way its activity and function are regulated. During T cell
development in the thymus and later in a differentiated and
specialized T cell type, cytotoxic T lymphocytes (CTLs), HDAC7
is regulated in a signal dependent manner responsible for its
phosphorylation and for its subsequent nucleo-cytoplasmic distri-
bution [26–31]. In resting thymocytes, HDAC7 is localized in the
nucleus, where it represses the expression of a large number of
genes involved in both positive (survival) and negative (apoptosis)
selection of the cells. However, in response to TCR signaling,
HDAC7 becomes phopshorylated and translocates to the
cytoplasm where it can no longer repress its target genes
[26,27,29,31]. Later in the periphery, HDAC7 is constitutively
phosphorylated and found in the cytoplasm of CTLs allowing the
expression of key genes for the function of this specialized T cell
type [30]. We could postulate that within a particular hemato-
poietic cellular lineage, the HDAC7 gene transcriptional
repressive function is regulated in a signal-dependent way by
controlling its phosphorylation status and altering its cellular
distribution. That is, HDAC7 is unphosphorylated or phos-
phorylated and localized either in the cell nucleus or in the
cytoplasm depending on the requirement to silence or activate
specific genes at different stages of T cell development. In
contrast, at the branching points where cellular lineage choice
has to be made, e.g. lymphoid versus myeloid, HDAC7 might
be regulated at the expression level. For instance, our results
showing that HDAC7 expression is down-regulated during the
conversion of pre-B cells into macrophages further support this
hypothesis. However, as is the case for T cells, we cannot rule
out the possibility that HDAC7 is additionally regulated in a
signal dependent manner during B cell development and
differentiation. In this regard, we have found that HDAC7 is
expressed in the nucleus of pre-B cells (data not shown) probably
due to the lack of a fully functional B cell receptor (BCR).
However, it is highly probable that HDAC7 function is also
regulated via BCR signaling at later cell differentiation stages
when B cells develop into mature antibody-secreting cells.
Based on the findings of this study, we therefore propose that in
the hematopoietic system, HDAC7 is not only a signal-dependent
transcriptional repressor involved in different developmental steps
of a particular lymphocyte type, but also a lineage-specific
transcriptional repressor responsible for maintaining the identity
of lymphocytes by silencing lineage inappropriate genes. We
anticipate that other members of the class IIa HDACs subfamily
might be specific repressors of undesirable genes in the cellular
differentiation and developmental processes where they exert their
actions (e.g. skeletal and cardiac muscle, bone formation and
brain).
Materials and Methods
Plasmids
MSCV-puro-HDAC7, MSCV-GFP-HDAC7, MSCV-GFP-
HDAC7(DMEF), MSCV-GFP-HDAC7(K86A/K88A), MSCV-
GFP-HDAC7(H657A), MSCV-GFP-HDAC7(1–487) and
MSCV-GFP-HDAC7(438–915) construct were generated by
cloning the HDAC7-Flag cDNA PCR amplificated from the
pCDNA3-HDAC7 wild-type and mutant plasmids previously
described [20] into the MSCV-puro or MSCV-GFP vectors
(Clontech).
Antibodies
Anti-HDAC7 (H-273), anti-HDAC7 (C-18), anti-HDAC4 (H-
92), anti-E2A (V-18), anti-PAX5 (C-20) and anti-RUNX1 (DW71)
were purchased from Santa Cruz Biotechnology. Anti-IKAROS
(ab26083) was purchased from Abcam; anti-MEF2C (D80C1) XP
from Cell Signaling Technology; and anti-a-Tubulin (T61999),
from Sigma-Aldrich.
Cxcl10 and Fcgr1 locus and amplicons scanned in Chromatin immunoprecipitation experiments by qPCR. Asterisks indicate MEF2 binding sites
location. D, E, G and H. Chromatin immunoprecipitation experiments showing the enrichment of HDAC7 and MEF2C to putative MEF2 binding sites
on the Cxcl10 and Fcgr1 gene loci in pre-B cells. Results are presented as percentage immunoprecipitated over input and are representative of three
independent experiments.
doi:10.1371/journal.pgen.1003503.g006
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Figure 7. HDAC7 re-expression interferes with the functional properties of the converted macrophages. A. Histograms for Mac-1 and
CD19 expression levels in C10-MSCV and C10-HDAC7 cells untreated or treated with b-estradiol for 72 hours. B. Mean fluorescence intensity (MFI) of
Mac-1 and CD19 of C10-MSCV and C10-HDAC7 cells untreated or treated with b-estradiol for 72 hours. Data are represented as the mean +/2
standard error of the mean (SEM) of three independent experiments. *P,0.001. C. Primary pre-B cells were transduced with the indicated retroviral
vectors and 48 hours after induce to transdifferentiate. Histograms for Mac-1 proteins levels are shown. D. Capacity of C10-MSCV and C10-HDAC7
cells untreated or treated with b-estradiol for 48 hours to phagocytose red fluorescence bacteria. Data are given as mean 6 SEM of values obtained
HDAC7 Is a Key Repressor in Pre-B Cells
PLOS Genetics | www.plosgenetics.org 12 May 2013 | Volume 9 | Issue 5 | e1003503
Cell culture and b-estradiol treatment
HAFTL cells were grown at 37uC in RPMI 1640 supplemented
with 10% fetal bovine serum, 2 mM glutamine, and 50 U/ml
streptomycin/penicillin. C10 cells (transduced with a MSCV-
GFP-C/EBPa retroviral vector) and C11 cells (transduced with a
MSCV-hCD4-C/EBPa retroviral vector) were cultured at 37uC in
RPMI 1640 without phenol red supplemented with 10% of
charcoal treated fetal bovine serum, 2 mM glutamine, and 50 U/
ml streptomycin/penicillin. B-cell precursors and macrophages
were obtained from mouse bone marrow as described [18]. For
transdifferentiation induction, cells were treated with 100 nM b-
estradiol in the presence of 10 nM of IL-3 and 10 nM of mCSF1
for the indicated periods of time.
Retroviral supernatant generation and cellular
transduction
For retrovirus generation the MSCV-puro, MSCV-puro-
HDAC7, MSCV-GFP, MSCV-GFP-HDAC7, MSCV-GFP-
HDAC7(DMEF), MSCV-GFP-HDAC7(K86A/K88A), MSCV-
GFP-HDAC7(H657A), MSCV-GFP-HDAC7(1–487) and MSCV-
GFP-HDAC7(438–915) plasmids were transfected into the pack-
aged cell line Platinum-E and supernatant were collected at 48–
in three independent experiments. Statistical significance was determined by two-way ANOVA followed by Bonferrony multiple comparison test.
*P,0.001. E. Effect of HDAC7 expression in LPS-mediated Tnfa, Il-1a and Il-6 gene expression. C10-MSCV and C10-HDAC7 cells were treated or not
with b-estradiol for 48 hours. Then, the cells where incuated or not with LPS for 6 hours and RNAs analyzed by RT-qPCR. Data are represented as the
mean +/2 standard error of the mean (SEM) of three independent experiments. P values were calculated by the two-way ANOVA test. *P,0.001.
doi:10.1371/journal.pgen.1003503.g007
Figure 8. Interaction of HDAC7 with MEF2C and its catalytic activity are essential for repression of Mac-1. C11 cells were infected with
MSCV-GFP, MSCV-GFP-HDAC7, MSCV-GFP-HDAC7(DMEF), MSCV-GFP-HDAC7(K86A/K88A), MSCV-GFP-HDAC7(H657A), MSCV-GFP-HDAC7(1–487) and
MSCV-GFP-HDAC7(438–915) viruses and induced with b-estradiol for 48 hours. A. Cells were stained with a Mac-1 antibody and the GFP-positive
fractions were gated and the results plotted. B. Percentage of Mac-1 positive cells treated with b-estradiol for 48 hours. Data are given as mean 6
SEM of values obtained in three independent experiments. Statistical significance was determined by two-way ANOVA followed by Bonferrony
multiple comparison test. *P,0.0001. C. RT-qPCR experiments for Itgam gene expression changes in cells treated with b-estradiol for 48 hours. Data
are given as mean6 SEM of values obtained in three independent experiments. Statistical significance was determined by two-way ANOVA followed
by Bonferrony multiple comparison test. *P,0.001.
doi:10.1371/journal.pgen.1003503.g008
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72 hours post-transfection. For the generation of C10-MSCV and
C10-HDAC7 cells, C10 cells were spin infected and 48 hours after
were selected in the presence of 3 ug/ml of puromycin. C11 cells were
spin infected with MSCV-GFP, MSCV-GFP-HDAC7, MSCV-GFP-
HDAC7(DMEF), MSCV-GFP-HDAC7(K86A/K88A), MSCV-
GFP-HDAC7(H657A), MSCV-GFP-HDAC7(1–487) and MSCV-
GFP-HDAC7(438–915) and 48 hours after treated with b-estradiol.
siRNA depletion
Dharmacon siRNA control and on-target smartpools targeting
transcript of the mouse HDAC7 gene were used to knockdown its
expression HAFTL cells and primary B cell precursors. siRNA
were transfected using Lipofectamine RNAiMAX Transfection
Reagent (Invitrogen). mRNA levels were examined by RT-qPCR
experiments 72 hours after siRNA transfection.
RT–qPCR experiments
RNA was extracted Trizol extraction (Qiagen) and cDNA
synthesyzed using the High Capacity cDNA Reverse Trancription
Kit (AB Applied Biosystems). RT-qPCR were performed in
triplicate using SYBR Green I Master (Roche). PCR reactions
were run and analyzed using the LightCycler 480 Detection
System (Roche). Primers sequences upon request.
Co-immunoprecipitation and Western blot analysis
Total cellular extracts were prepared in PLB buffer (0.5%
Triton X-100, 0.5 mM EDTA, 1 mM DTT in PBS) supplement-
ed with protease inhibitors (Complete, Roche Molecular Bio-
chemicals). Immunoprecipitation, SDS-PAGE and Western blot
experiments were performed as previously described [32].
Flow cytometry
Cells were un-induced or induced to transdifferentiate.
48 hours later, cells were stained with fluorochrome conjugated
antibodies against Mac-1 and CD19 (BD Pharmingen). Mac-1
and CD19 expression were monitored on a Gallios Flow
Cytometer (Beckman Coulter) and analyzed by FlowJo software
(Tree Star, Inc.).
Figure 9. Model for HDAC7-mediated transcriptional repression in pre-B cells. HDAC7 is expressed in pre-B cells and not in macrophages.
In pre-B cells, HDAC7 specifically interacts with the transcription factor MEF2C and is recruited to promoters of myeloid genes. During
transdifferentiation of pre-B cells into macrophages HDAC7 is down-regulated allowing for expression of macrophages specific genes.
doi:10.1371/journal.pgen.1003503.g009
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Phagocytosis assays
C10-MSCV and C10-HDAC7 cells were induced or not for
48 h and subjected to the pHrodo E.coli phagocytosis KiT
(Invitrogen) following the manufacturers protocol.
LPS induced inflammatory cytokines
C10-MSCV and C10-HDAC7 cells were induced to transdif-
ferentiate. 48 h after induction they were incubated with LPS
(1 mg/mL Sigma) for 6 h. RNA extraction, cDNA synthesis and
RT-qPCR were performed as described above. Primers sequences
upon request.
Microarray experiments
Biological duplicates of C10-MSCV and C10-HDAC7 cells
were un-induced or induced to transdifferentiate for 48 and
72 hours (12 samples in total). Total RNA from cultured cells was
extracted by Trizol and then purified. PCR amplified RNAs were
hybridized against Affymetrix mouse arrays chip (Mouse Genome
430 PM strip) at the IRB Genomics Facility. Affymetrix raw CEL
files and processed (normalized) data have been deposited in GEO
database under accession number GSE36827.
Microarray data analysis
Affymetrix CEL files were background corrected, normalized
using Bioconductor, package ‘‘affy’’ (version 1.28.1) using ‘expres-
so’ algorithm [33,34]. Since the Affymetrix chip version used in
this study contains only perfect match (pm) probes, for
normalization and acquiring raw probe intensities to expression
values we used the following parameters: background correction
method ‘‘rma’’; normalization method ‘‘constant’’; pm correct
method ‘‘pmonly’’; and summary method ‘‘avgdiff’’. Quality of
microarray experiment (data not shown) was verified by
Bioconductor package ‘‘arrayQualityMetrics’’ (version 3.2.4
under Bioconductor version 2.7; R version 2.12.1) [35]. To
determine genes that are differentially expressed (DE) between
two experimental conditions, Bioconductor package Limma was
utilized to generate contrast matrices and fit the corresponding
linear model [36]. Probe to gene annotation were performed
using microarray vendor’s annotation data. When more than
one probe were annotated to same gene, highest absolute
expression value was considered (maximizing). To consider a
gene is differentially expressed, besides multiple test corrected,
FDR p-value #0.05 as cut off, we also applied Log2 fold change
(Log2FC) cut off 0.5 for b-estradiol treatment. We used Log2FC
cut off 0.5 for genes that are affected by the expression of
HDAC7 in b-estradiol treated cells. Expression data on Mef2c
deficient multipotent progenitor cells were obtained from GEO
database (accession No. GSE13686) [5]. Data were analyzed
using the limma package from Bioconductor. Spots were not
background corrected before within array loess normalization.
After array normalization using the quantile method log2 ratios
(mutant/control) was calculated. To define a gene up-regulated,
we used Log2FC $1.0.
Functional and pathway enrichment analysis
Functional annotation of differentially expressed genes is based
on Gene Ontology (GO) (http://www.geneontology.org) as
extracted from EnsEMBL and KEGG pathway database.
Accordingly, all genes are classified into three ontology categories
(i) biological process (BP), (ii) cellular component, (CC) and
molecular function (MF) and pathways when possible. We have
taken only the GO/pathway categories that have at least 10 genes
annotated. We used Gitools for enrichment analysis and heatmap
generation (www.gitools.org). Resulting p-values were adjusted for
multiple testing using the Benjamin and Hochberg’s method of
False Discovery Rate (FDR).
Chomatin immunoprecipitations assays
ChIP was performed essentially as previously described [32] on
C10 cells un-induced or induced for 72 hours. To shear chromatin
to an apparent length of ,500 bp, chromatin was sonicated using
a BioRuptor sonicator (Cosmo Bio Co., Ltd) with either 40 45-s
pulses (uninduced cells) or 30 45-s pulses (induced cells) at
maximum setting. Input and immunoprecipitated DNA were
subjected to Sybergreen Q PCR cycles with specific primers
(provided upon request).
Supporting Information
Dataset S1 Microarray statistics analysis for genes up-regulated
during the conversion of pre-B cells into macrophages that are
affected by HDAC7.
(XLS)
Dataset S2 Microarray statistics analysis for genes down-
regulated during the conversion of pre-B cells into macrophages
that are affected by HDAC7.
(XLS)
Figure S1 HDAC7 is down-regulated during the transifferentia-
tion of pre-B cells into macrophages. Kinetics of regulation (log2
Affymetrix expression values) of Hdac7 and Pax5 genes in C10 cells
and primary pre-B cells transduced with a retroviral vector for
inducible expression of C/EBPa. Cells were treated with b-
estradiol for the times indicated. HAFTL cells, primary pre-B cells,
primary bone marrow macrophages and RAW264.7 cells were
used as control.
(EPS)
Figure S2 Western blot showing the protein levels of endoge-
nous and exogenously expressed HDAC7 in C10 cells transduced
with a untreated or treated with b-estradiol for 72 hours.
(EPS)
Figure S3 HDAC7 re-expression interferes with the gene
transcriptional program of the converted macrophages. A. Heat-
map statistics showing significantly (FDR p-value #0.05) enriched
KEGG pathways among the up-regulated genes affected by the re-
expression of HDAC7 during transdifferentiation of pre-B cells
into macrophages. Colours toward red indicate high statistic
significance, yellow indicates low statistic significance, and gray
indicates no statistic significance. B. Heat-maps showing observed
differentially expressed genes for selected KEGG pathways. Blue
colour cell indicates positive events while gray colour indicates that
the gene was not observed differentially expressed in that
experimental condition.
(EPS)
Figure S4 HDAC7 re-expression interferes with the gene
transcriptional program of the converted macrophages. Heatmap
statistics showing significantly (FDR p-value #0.05) enriched A.
GO Biological Processes categories, B. GO Cellular Components
categories, C. GO Molecular Functions categories and D. KEGG
pathways, among the down-regulated genes affected by the re-
expression of HDAC7 during transdifferentiation of pre-B cells
into macrophages. Colours toward red indicate high statistic
significance, yellow indicates low statistic significance, and gray
indicates no statistic significance.
(EPS)
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Figure S5 HDAC7 re-expression does not interfere with the
down-regulation of Pax5. A. Kinetics of down-regulation (log2
Affymetrix expression values) of Pax5 in C10-MSCV and C10-
HDAC7 cells un-treated or treated with b-estradiol for the
times indicated. B. RT-qPCR validation of the results shown
in A.
(EPS)
Figure S6 HDAC7 is recruited to the Itgam promoter in pre-B
cells. A. Schematic representation of the mouse Itgam locus and
amplicons scanned in Chromatin immunoprecipitation experi-
ments by qPCR. Asterisks indicate MEF2 binding sites location. B.
Chromatin immunoprecipitation experiments showing the enrich-
ment of HDAC7 and MEF2C to putative MEF2 binding sites on
the Itgam gene loci in pre-B cells. Results are presented as
percentage immunoprecipitated over input and are representative
of three independent experiments.
(EPS)
Figure S7 HDAC7 re-expression decreases Mac1 protein levels
in the reprogrammed macrophages. A. Histograms for Mac-1
protein levels in reprogrammed machrophages transduced with
either an empty vector or a retroviral vector for HDAC7
expression. B. Histograms for Mac-1 and CD19 protein levels in
RAW-MSCV and RAW-HDAC7 cells. C. RT-qPCR experi-
ments for gene expression changes for Hdac7, Itgam, Ccl3, and
Fcgr1 genes in RAW-MSCV and RAW-HDAC7 cells. D.
Capacity of RAW-MSCV and RAW-HDAC7 cells to phagocytose
red fluorescence bacteria.
(EPS)
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